ICON PUBLIC LIMITED COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 214.50 USD | +0.71% |
|
+0.78% | -24.22% |
| Dec. 02 | Nephron Upgrades ICON to Buy, Price Target is $280 | MT |
| Nov. 25 | Fed minutes and inflation data set to stir Thanksgiving week |  |
Highlights: ICON Public Limited Company
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses: ICON Public Limited Company
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings Chart: ICON Public Limited Company
Source: Surperformance
ESG chart: ICON Public Limited Company
Source: Refinitiv
| Composite Fundamentals | Composite Valuation | Composite Momentum | Capi. ($) | ||
|---|---|---|---|---|---|
| 17.71B | |||||
| 43.21B | |||||
| 36.88B | |||||
| 26.71B | |||||
| 16.71B | |||||
| - | 16.02B | ||||
| 12.06B | |||||
| 10.74B | |||||
| 10.19B | |||||
| 9.73B | |||||
| Average | 20B | ||||
| Weighted average by Cap. |
Investor Rating
Trading Rating
ESG Refinitiv
B-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ICLR Stock
- Ratings ICON Public Limited Company